Skip to main content

and
  1. No Access

    Article

    Cyclic sulfur compounds targeting macrophage polarization into M2/protumor phenotype and their anti-tumor effects

    Tumor-associated macrophages (TAMs), especially the M2-like phenotype, promote tumor progression, making them candidate targets for anti-tumor therapy. We previously discovered a cyclic sulfur compound, Onioni...

    Cheng Pan, Yukio Fujiwara, Hasita Horlad in Cancer Immunology, Immunotherapy (2022)

  2. No Access

    Article

    CD163-positive cancer cells are potentially associated with high malignant potential in clear cell renal cell carcinoma

    CD163 is preferentially expressed by monocyte/macrophages; however, recent studies using immunohistochemistry (IHC) have reported that some cancer cells also express CD163. In the present IHC study, we investi...

    Chaoya Ma, Hasita Horlad, Koji Ohnishi, Takenobu Nakagawa in Medical Molecular Morphology (2018)

  3. No Access

    Article

    Chronic inflammation with Helicobacter pylori infection is implicated in CD44 overexpression through miR-328 suppression in the gastric mucosa

    Infection with Helicobacter pylori is the main risk factor for development of gastric cancer. CD44 overexpression, especially that of variant 9 (CD44v9), has also been implicated in the local inflammatory respons...

    Takatsugu Ishimoto, Daisuke Izumi, Masayuki Watanabe in Journal of Gastroenterology (2015)

  4. No Access

    Article

    Hepatic Stellate Cells Accelerate the Malignant Behavior of Cholangiocarcinoma Cells

    Although tumor–stromal interaction has been discussed, the role of hepatic stellate (HS) cells against cancer, especially cholangiocarcinoma (CC), has not been clarified. The aim of this study is to investigat...

    Hirohisa Okabe MD, Toru Beppu PhD, Hiromitsu Hayashi PhD in Annals of Surgical Oncology (2011)

  5. No Access

    Article

    Intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy

    We aimed to clarify the histological features of and risk factors for intrahepatic dissemination after local ablation therapy (LAT) for hepatocellular carcinoma (HCC).

    Toshiro Masuda, Toru Beppu, Takatoshi Ishiko in Journal of Hepato-Biliary-Pancreatic Surge… (2008)